We are live on ! Find out more
GMDA

Gamida Cell Ltd. Ordinary Shares

Delisted

GMDA was delisted on the 5th of April, 2024.

52 hedge funds and large institutions have $13.2M invested in Gamida Cell Ltd. Ordinary Shares in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 17 increasing their positions, 4 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,194% more call options, than puts

Call options by funds: $220K | Put options by funds: $17K

325% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 4

13% less funds holding

Funds holding: 6052 (-8)

62% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 13

62% less capital invested

Capital invested by funds: $35.3M → $13.2M (-$22.1M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
52
Holders Change
-8
Holders Change %
-13.33%
% of All Funds
0.76%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
5
Increased
17
Reduced
4
Closed
13
Calls
$220K
Puts
$17K
Net Calls
+$203K
Net Calls Change
+$188K
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$3.32M
LCS
2
Levin Capital Strategies
New York
$2.49M +$1.88M +3,330,355 +124%
MIH
3
Meitav Investment House
Israel
$1.51M
Millennium Management
4
Millennium Management
New York
$1.06M +$1.45M +2,568,866 New
KHLMVGHM
5
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet
Israel
$912K
AIM
6
ARK Investment Management
Florida
$885K +$409K +724,806 +51%
Mariner
7
Mariner
Kansas
$422K +$166K +294,522 +40%
Renaissance Technologies
8
Renaissance Technologies
New York
$395K +$541K +957,581 New
KHLMTHM
9
Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet
Israel
$331K
NCM
10
Nantahala Capital Management
Connecticut
$330K -$1.99M -3,525,000 -82%
Susquehanna International Group
11
Susquehanna International Group
Pennsylvania
$267K +$4.17K +7,394 +1%
Squarepoint
12
Squarepoint
New York
$224K +$306K +542,741 New
Morgan Stanley
13
Morgan Stanley
New York
$163K +$138K +245,171 +163%
Qube Research & Technologies (QRT)
14
Qube Research & Technologies (QRT)
United Kingdom
$139K +$172K +304,567 +912%
CCM
15
Corsair Capital Management
New York
$127K +$84.8K +150,152 +96%
BlackRock
16
BlackRock
New York
$119K +$38.6K +68,387 +31%
LIM
17
Leavell Investment Management
Alabama
$97K
Group One Trading
18
Group One Trading
Illinois
$93K +$35.3K +62,592 +38%
Commonwealth Equity Services
19
Commonwealth Equity Services
Massachusetts
$61K +$65.3K +115,700 +366%
Two Sigma Investments
20
Two Sigma Investments
New York
$51.3K +$62.7K +111,126 +848%
SYBT
21
Stock Yards Bank & Trust
Kentucky
$41.3K +$28.2K +50,000 +100%
Geode Capital Management
22
Geode Capital Management
Massachusetts
$34.6K +$17.2K +30,397 +57%
PTP
23
Platform Technology Partners
New York
$33.1K +$4.52K +8,000 +10%
Cambridge Investment Research Advisors
24
Cambridge Investment Research Advisors
Iowa
$30K +$19.8K +35,000 +93%
PF
25
Phoenix Financial
Israel
$13.6K

GMDA Hedge Fund Activity: Q4 2023 in Review

52 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Gamida Cell Ltd. Ordinary Shares (GMDA) for Q4 2023, worth a combined $13.2M — down 62% from $35.3M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of GMDA and 5 opened new positions — a net loss of 8 holders — while 4 trimmed existing stakes and 17 added.

The largest buyer was Levin Capital Strategies, adding an estimated $1.88M. The largest seller was Stonepine Capital Management, exiting entirely with an estimated $8.2M sold.

  • 52 institutional investors held Gamida Cell Ltd. Ordinary Shares (GMDA) as of Q4 2023, down from 60 in Q3 2023.
  • Funds reported $13.2M of Gamida Cell Ltd. Ordinary Shares stock for Q4 2023, down 62% quarter-over-quarter.
  • 5 funds opened new Gamida Cell Ltd. Ordinary Shares positions in Q4 2023 and 13 closed out, a net change of -8 holders.
  • The largest Gamida Cell Ltd. Ordinary Shares buyer in Q4 2023 was Levin Capital Strategies, an estimated $1.88M added.
  • The largest Gamida Cell Ltd. Ordinary Shares seller in Q4 2023 was Stonepine Capital Management, an estimated $8.2M sold.

Based on aggregated 13F filings for Q4 2023.